US Patent Issued to Medizinische Hochschule Hannover, Technische Universitat Braunschweig on Nov. 11 for "Fusion protein for use in the treatment of HVG disease" (German Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,871, issued on Nov. 11, was assigned to Medizinische Hochschule Hannover (Hannover, Germany) and Technische Universitat Braunschweig (Braunschweig, Germany).

"Fusion protein for use in the treatment of HVG disease" was invented by Elmar Jackel (Hannover, Germany), Fatih Noyan (Hannover, Germany) and Michael Hust (Braunschweig, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A fusion protein for use in the treatment of HvG disease in a patient having received a transplant, for use in suppressing the host's immune response directed against the transplant. The fusion protein is adapted for use in suppressing the immune rejection of a transplant ...